Astronics (ATRO) Q1 2026 earnings review
Record Backlog and Aerospace Strength Fuel Strong Start to 2026
Astronics delivered a robust 26Q1, with revenue growing 12% YoY to $230.6M and Net Income surging 168% to $25.5M. The Aerospace segment remains the undisputed growth engine, driving a 540 basis point expansion in consolidated operating margins. While profitability metrics are healthy, the true highlight is forward-looking: record quarterly bookings of $290.4M pushed the backlog to an all-time high of $734.3M. This visibility gave management the confidence to raise FY26 revenue guidance to a range of $970M to $1B. However, elevated capital expenditures and a massive new ERP investment resulted in slightly negative free cash flow for the quarter, reminding investors that aggressive expansion carries high near-term costs.
🐂 Bull Case
Bookings generated a 1.26 book-to-bill ratio, swelling the backlog to $734.3M. Approximately 81% of this backlog is expected to convert to revenue within the next twelve months, heavily de-risking FY26 guidance.
Consolidated operating margin accelerated to 11.8% from 6.4% a year ago. The integration of Bühler Motor Aviation and the resolution of past UK patent litigation are allowing core operational leverage to shine through.
🐻 Bear Case
Despite a massive jump in Net Income, Free Cash Flow was slightly negative (-$0.6M) due to $11.2M in catch-up CapEx and inventory build-up. An upcoming $35-$40M ERP system implementation will further strain cash generation over the next few years.
The Test Systems segment eked out a $0.4M profit, but remains heavily under-absorbed. It desperately needs the U.S. Army radio test production award—expected 'in the coming weeks'—to finally execute its turnaround.
⚖️ Verdict: 🟢
Bullish. Astronics is successfully capitalizing on the commercial aerospace upcycle. The record backlog and raised guidance overshadow the temporary cash flow headwinds associated with capacity expansion.
Key Themes
Commercial Transport Driving Aerospace Growth
Accelerating. The Aerospace segment remains the company's workhorse, with sales rising 11.7% YoY to $213.8M. This was propelled by a 13.7% jump in the Commercial Transport market ($156.4M), driven by intense demand for seat motion, lighting, and safety products. Additionally, General Aviation surged 40.7% due to inflight entertainment & connectivity (IFEC) retrofits in the VVIP market.
Operating Leverage is Materializing
Stable and strong. Adjusted EBITDA margin expanded to 16.4% from 14.9% YoY. Management explicitly pointed to leverage gained on higher volume and improved production efficiencies in the Aerospace segment (16.5% operating margin). The pricing actions initiated in 2024 and 2025 are successfully protecting margins against ongoing cost pressures.
Test Systems Breakeven Reached
Reversing. The Test Systems segment flipped from a brutal 15.3% operating loss in 25Q1 to a 2.4% operating profit in 26Q1. While current margins are still suffering from under-absorption of fixed costs, recent cost rationalization activities have stabilized the floor. Bookings of $26.1M (1.55 book-to-bill) indicate incoming demand.
Heavy Investment Cycle Suppressing Cash Flow
Despite reporting $25.5M in Net Income, Free Cash Flow was negative -$0.6M ($10.6M operating cash minus $11.2M CapEx). This contradicts the 'strong earnings' narrative. The drain stems from working capital requirements (inventory build) and a major facility consolidation in Seattle. Management expects to return to positive FCF for the remainder of the year, but capital intensity will remain high.
Massive ERP Implementation Launch
Astronics announced a new 5-year global ERP system implementation that will cost $35M-$40M. In 2026 alone, it will consume $15M-$17M, largely reported as a cash outflow from operations. This represents a significant long-term execution risk and will suppress reported operating cash flows through the end of the decade.
Tariff Drag Remains Persistent
Stable. The macro headwind of tariffs continues to bite, with Q1 Gross Profit being partially offset by a $1.7M increase in tariff expenses. While smaller than the $2.9M hit in 25Q4, it shows that global supply chain realignment is not yet fully shielding the bottom line.
U.S. Army Radio Test Program Timing
Decelerating. This catalyst has been repeatedly delayed. Originally expected to ramp in late 2025, then early 2026, management now states a production award is 'on track to be issued in the coming weeks.' Until the 4549/T radio test program officially begins production, Test Systems profitability will remain highly vulnerable to volume shortfalls.
Litigation Headwinds Dissipating
Reversing. SG&A expenses benefited from a $1.2M reduction in litigation-related costs YoY. Furthermore, 25Q1 included a massive $6.2M reserve adjustment for a UK patent dispute. With appeals scheduled for July 2026, the company is finally moving past a period of heavy, unpredictable legal cash burn.
Other KPIs
Accelerating. Up 120 basis points from 16.2% a year ago. This reflects improved factory execution and a $2.8 million cumulative catch-up profit on the MV-75 program based on revised cost estimates.
Decelerating. Down 25.8% YoY from $3.15 million. This is the direct result of the successful September 2025 refinancing activities which swapped expensive 5.5% convertible bonds for 0% convertible bonds, fundamentally de-risking the balance sheet.
A tailwind driven by a $2.7M discrete adjustment for stock-based compensation deductions and valuation allowance reversals, shifting the company from a $0.6M tax expense in the prior-year period to a net benefit.
Guidance
Accelerating. Management explicitly raised guidance here, targeting an aggressive ~14% increase over FY25's $862M. Given that 81% of the $734M backlog is scheduled to ship within twelve months, the visibility to achieve this is exceptionally high.
Accelerating. The midpoint of $247.5M implies a nearly 21% YoY growth rate vs 25Q2 ($204.7M). If achieved, this will set a new all-time quarterly revenue record for the company, sequentially stepping up from Q1.
Stable. This remains highly elevated compared to historical norms, driven largely by the completion of the Seattle operation consolidation expected in Q2 2026.
Key Questions
ERP Implementation Risks
You are embarking on a 5-year, $40M global ERP implementation. Given the history of manufacturing companies experiencing severe supply chain disruptions during ERP cutovers, what specific operational safeguards are in place to ensure this doesn't disrupt your record $734M backlog?
Test Systems Turnaround Viability
You noted a production award for the Army radio test program is expected 'in coming weeks.' If this timeline slips further into late 2026, what levers remain to keep the Test Systems segment out of operating losses?
Tariff Mitigation Progress
Q1 saw a $1.7M gross profit hit from tariffs. What percentage of your supply chain realignment is currently complete, and when do you expect tariff impacts to become immaterial to consolidated margins?
MV-75 Program Trajectory
You booked a $2.8M catch-up profit on the MV-75 program due to revised estimates. Does this signal that the development phase margins are permanently improving, and what does this mean for the margin profile as it shifts fully into production?